Clinical Trial Update: Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides [Phase 1]

View source ↗

Summary

Phase Ia trial update of a virosome-formulated peptide malaria vaccine for falciparum malaria. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Virosome-formulated malaria vaccine peptides

Snippet

Sponsor: Swiss Tropical & Public Health Institute | Conditions: Falciparum Malaria | Phase 1 | Status: TERMINATED